Cargando…
OBP-801, a novel histone deacetylase inhibitor, induces M-phase arrest and apoptosis in rhabdomyosarcoma cells
Autores principales: | Tomoyasu, Chihiro, Kikuchi, Ken, Kaneda, Daisuke, Yagyu, Shigeki, Miyachi, Mitsuru, Tsuchiya, Kunihiko, Iehara, Tomoko, Sakai, Toshiyuki, Hosoi, Hajime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412392/ https://www.ncbi.nlm.nih.gov/pubmed/30720122 http://dx.doi.org/10.3892/or.2019.6997 |
Ejemplares similares
-
Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells
por: Ouchi, Kazutaka, et al.
Publicado: (2020) -
In ovo chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma
por: Shoji, Chika, et al.
Publicado: (2023) -
Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma
por: Kanayama, Takuyo, et al.
Publicado: (2021) -
Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma
por: Kubo, Hiroshi, et al.
Publicado: (2021) -
Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma
por: Miyagaki, Satoshi, et al.
Publicado: (2021)